Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Sawit Sumbermas Sarana Tbk (SSMS)

UBC Medical Indonesia Tbk.Trading
Sawit Sumbermas Sarana TbkTrading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Sawit Sumbermas Sarana Tbk: UBC Medical Indonesia Tbk. diperdagangkan di Rp162 (kapitalisasi pasar 635,95 M, volume 24 jam 324,5 rb), sedangkan Sawit Sumbermas Sarana Tbk diperdagangkan di Rp880 (kapitalisasi pasar 8,67 T, volume 24 jam 7,75 jt). Perbedaan utamanya: Sawit Sumbermas Sarana Tbk jauh lebih besar — sekitar 13,6× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Sawit Sumbermas Sarana Tbk lebih aktif diperdagangkan (7,75 jt vs 324,5 rb). Mana yang lebih baik tergantung tujuan investasimu.

LABSSSMS
Kapitalisasi Pasar
635,95 M8,67 T
Volume
324,5 rb7,75 jt
Lot
3,25 rb77,46 rb
Perputaran
52,71 jt6,87 M
Harga Rata-rata
162,44887,44
Nilai Transaksi
52,71 jt6,87 M
Harga Ekuilibrium Indikatif
163920
Volume Ekuilibrium Indikatif
16212

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail
SSMS
Lihat detail

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS

Tentang Sawit Sumbermas Sarana Tbk

PT Sawit Sumbermas Sarana Tbk (the Company) was established in Jakarta based on the Notarial Deed No. 51 of Enimarya Agoes Suwarko, S.H., dated November 22, 1995.

Selengkapnya di halaman SSMS